Hyperglycemia is a common feature of the critically ill patient and has been associated with increased mortality. Maintaining normoglycemia with insulin therapy improves survival and reduces morbidity in surgical ICU patients, as shown by a large randomized controlled study. Prevention of glucose toxicity by strict glycemic control but also other metabolic and non-metabolic effects of insulin contribute to these clinical benefits.
Department of Intensive Care Medicine, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium
Corresponding author
Dr. Langouche is a Post Doctoral Fellow of the FWO Flanders Belgium. Dr. Van den Berghe holds an unrestrictive Catholic University of Leuven Novo Nordisk Chair of Research.